Bosutinib: a new, safer TKI for frontline CML VJHemOnc – Video Journal of Hematology & HemOnc 1:03 6 years ago 965 Скачать Далее
Bosutinib in newly diagnosed CML: GI, liver, effusion, and renal safety characterization VJHemOnc – Video Journal of Hematology & HemOnc 2:32 2 years ago 251 Скачать Далее
5-year update of BFORE: bosutinib vs imatinib in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 378 Скачать Далее
Comparing Bosutinib Versus Imatinib in Newly Diagnosed CML Targeted Oncology 2:53 7 years ago 1 100 Скачать Далее
The BYOND trial: bosutinib shows promise in heavily pre-treated CML patients VJHemOnc – Video Journal of Hematology & HemOnc 2:04 3 years ago 236 Скачать Далее
Five-year follow-up data from the BFORE trial: bosutinib versus imatinib in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:54 1 year ago 226 Скачать Далее
Bosutinib Tablets 500mg Explained in Simple Words - Anti Cancer Tablets | Cancer Treatment Medicines Drug Net 0:20 1 year ago 432 Скачать Далее
How to use Bosulif - Explain Uses,Side Effects,Interactions Health A-Z 7:01 5 months ago 75 Скачать Далее
Final results of the BFORE trial: bosutinib vs imatinib in CP-CML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 1 year ago 321 Скачать Далее
FDA Approves Bosutinib for Pediatric Chronic Myelogenous Leukemia Patients Medical Dialogues 2:52 10 months ago 78 Скачать Далее
Tolerability of bosutinib vs asciminib in heavily pre-treated patients with CML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 1 year ago 158 Скачать Далее
What are the efficacy and safety considerations of bosutinib therapy? MediCom Oncology 3:09 8 years ago 188 Скачать Далее
